RG-6333
Product Specifications
Target
Immunology/Inflammation related
Related Pathways
Immunology/Inflammation
Bioactivity
RG-6333 is a bispecific agonist targeting CD19 and CD28. It specifically identifies and binds to the CD19 antigen present on the surface of malignant B cells, effectively targeting tumor cells. By engaging with CD28, RG-6333 activates T cells, overcoming activation barriers and boosting antitumor immunity. RG-6333 is applicable for research in relapsed/refractory non-Hodgkin lymphoma.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/348162468582785047/T9901A-873
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Poly (ethylene glycol) [PEG MW 10,000 - 16,000]](https://cdn.genprice.uk/genprice/genprice5.png)
GTR15090246 1 Vial
Lentiviral human PRDM15 shRNA (UAS) - Lentiviral human PRDM15 shRNA (UAS) (100)
Ask
View Details